tiprankstipranks
Pharma Mar SA (PHMMF)
OTHER OTC:PHMMF
US Market
PHMMF
Pharma Mar SA
RESEARCH TOOLSreports
Want to see PHMMF full AI Analyst Report?

Pharma Mar SA (PHMMF) Financial Statements

57 Followers

Pharma Mar SA Financial Overview

Pharma Mar SA's market cap is currently $2.01B. The company's EPS TTM is $3.9262821599999995; its P/E ratio is 17.19; and it has a dividend yield of 1.04%. Pharma Mar SA is scheduled to report earnings on February 27, 2026, and the estimated EPS forecast is $0.15. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue€ 221.39M€ 174.85M€ 158.15M€ 196.34M€ 229.83M
Gross Profit€ 209.13M€ 166.67M€ 148.54M€ 182.70M€ 213.39M
Operating Income€ 40.28M€ 6.47M€ -3.83M€ 44.07M€ 92.45M
EBITDA€ 48.30M€ 21.23M€ 4.55M€ 52.07M€ 104.08M
Net Income€ 74.99M€ 26.13M€ 1.14M€ 49.36M€ 92.86M
Balance Sheet
Cash & Short-Term Investments€ 167.22M€ 154.53M€ 162.56M€ 182.42M€ 201.88M
Total Assets€ 395.08M€ 349.64M€ 340.52M€ 393.26M€ 368.39M
Total Debt€ 49.41M€ 51.08M€ 43.67M€ 42.63M€ 49.33M
Net Debt€ 31.60M€ -12.16M€ -16.36M€ -107.18M€ -64.02M
Total Liabilities€ 143.25M€ 141.28M€ 147.08M€ 170.30M€ 190.47M
Stockholders' Equity€ 251.83M€ 208.36M€ 193.44M€ 222.96M€ 177.92M
Cash Flow
Free Cash Flow€ 43.75M€ -9.48M€ -29.40M€ 29.47M€ 17.87M
Operating Cash Flow€ 53.13M€ 6.03M€ -13.45M€ 38.32M€ 25.68M
Investing Cash Flow€ -60.79M€ 1.03M€ -43.05M€ 10.88M€ 18.47M
Financing Cash Flow€ -36.52M€ -5.35M€ -32.14M€ -13.37M€ -27.41M
Currency in EUR

Pharma Mar SA Earnings and Revenue History

Income Statement >

Pharma Mar SA Debt to Assets

Balance Sheet >

Pharma Mar SA Cash Flow

Cash Flow >

Pharma Mar SA Forecast EPS vs Actual EPS

Earnings >